TrialJournal of bone and mineral metabolism2023

Abaloparatide dose-dependently increases bone mineral density in postmenopausal women with osteoporosis: a phase 2 study.

Toshio Matsumoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.